Fundraising Fox
FindMeCure
Techstars '17Berkhamsted, GB · 29 employees on LinkedIn · 4 known investors
Find your way into FindMeCure
Sign up to see every warm intro you have to FindMeCure
- Paths you didn't know you had: your email and LinkedIn already hold routes to the FindMeCure team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
FindMeCure is a platform that helps patients find and plan clinical trials for medical treatments. It serves patients seeking experimental or specialized treatment options.
Also known as FindMeCure Foundation
Investors · 4
How we know: LAUNCHub Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: the Techstars portfolio · funding news · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeed RoundJan 2023Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Company profile
researched Sep 2026FindMeCure operates a platform that lets patients search for, understand and apply to clinical trials online, positioning trial participation as an alternative treatment option for conditions with no approved therapy. The company frames its mission around the view that diseases are not incurable but rather lack a cure that has yet to be found.
Alongside the patient-facing service, FindMeCure works with pharmaceutical and research organisations, aggregating and analysing large numbers of data sources to advise sponsors on where and how to run a clinical trial and how to engage patients, with the stated aim of avoiding recruitment delays. The company also runs the FindMeCure Foundation, which covers patient support, mentorship and education, publishes newsletters and other resources, holds events, and maintains pages on its partners, documents and financial transparency.
Founding story
The company originated from a personal problem faced by CEO Maya Zlatanova, whose sister had a disease with no available treatment. Despite Zlatanova's more than ten years of experience in the clinical research industry as a speaker and author on patient engagement, locating a suitable clinical trial proved difficult. After others began asking her for similar help, she concluded that lack of awareness and support was a widespread patient problem, and partnered with clinical trial software developers Ivaylo Yosifov (CTO) and Miroslav Valchev (COO) to launch FindMeCure. Yosifov had been one of the lead developers behind the British National Clinical Trial Register and Valchev worked on its Australian equivalent.
Business model
Two-sided model: a free-to-use patient search and application service for clinical trials, paired with data and analytics services sold to pharmaceutical and research companies that need patient perspective and site/recruitment planning input for new clinical trials.
Traction
The company states it has helped a large number of people find, understand and join clinical trials as an alternative treatment option.
Latest developments
Stated forward plan is to decentralise trials so that participation can happen at the patient's home rather than requiring travel to a distant participating hospital, an objective management described as at least five years out.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
Operates in patient recruitment and clinical trial access, serving both patients and industry sponsors; a Techstars London alumnus and a member of the Campus X community in Bulgaria.
The company attributes its approach to putting patients first and to simplifying patient recruitment: patients can find, understand and apply for a trial online, whereas trial access has conventionally required a doctor already involved in a trial.
Technology
The platform aggregates thousands of data sources on clinical trials and analyses them to support patient trial matching and to inform sponsors' decisions on trial location and design. The founding technical team previously built national clinical trial registers in the UK and Australia.
Go-to-market
Patients seeking treatment options through clinical trials, particularly those with conditions lacking approved therapies, and pharmaceutical and clinical research organisations planning patient recruitment for trials.
Geography
Roots and team presence in Bulgaria, including membership of the Campus X community in Sofia; investor base spans UK and Bulgarian investors; participation in the Techstars London programme.
History
FindMeCure was initially financed by its co-founders using proceeds from their earlier software consultancy business. In 2017 it took part in the Techstars London accelerator programme and subsequently received funding from LAUNCHub Ventures as well as UK and Bulgarian investors. The company later became a member of the Campus X startup community, where it outsourced day-to-day office administration in order to focus on growth.
Risks & controversies
Management notes that the complexity of the pharmaceutical industry makes seemingly simple problems difficult to solve, and points to trial designs with long eligibility criteria lists and participating sites far from patients as barriers to enrolment.
Compiled by commissioned research from 3 cited public sources — announcements, filings, and press listed under research sources below.
Timeline · 2
launches, deals, and filingsFollowing the Techstars London programme, the company received further funding from LAUNCHub Ventures along with UK and Bulgarian-based investors. Amount not disclosed.
FindMeCure participated in the Techstars London accelerator programme.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
Legal entities · 1
corporate structureCompanies House · registry record
View on Companies House ↗- Registered name
- FINDMECURE LTD
- Company number
- 10821379
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 15 Jun 2017
- Registered office
- 86-90 Paul Street, London, EC2A 4NE
- Nature of business (SIC)
- 62012 — Business and domestic software development
- Accounts
- last made up to 30 Jun 2025 · next due 31 Mar 2027
- Confirmation statement
- last made up to 14 Jun 2026 · next due 28 Jun 2027
Current officers · 3
- Miroslav Valchev — director, appointed 15 Jun 2017
- Ivaylo Yosifov — director, appointed 15 Jun 2017
- Maya Zlatanova — director, appointed 15 Jun 2017
Source: Companies House public register · retrieved 24 Jul 2026. Contains public sector information licensed under the Open Government Licence v3.0.
▸Research sources · 3
primary sources listed
- Hristo Tenchev (investor) | Nordic 9nordic9.com · web
3 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does FindMeCure do?
- FindMeCure helps patients find, understand and join clinical trials, and supplies trial-planning data to pharma and research firms.
- Who are FindMeCure's investors?
- FindMeCure's investors include LAUNCHub Ventures, Techstars, Fortech Investments, Techstars Ventures 2022.
- Where is FindMeCure headquartered?
- FindMeCure is headquartered in Berkhamsted, GB.